8
Participants
Start Date
May 31, 2007
Primary Completion Date
May 31, 2011
Study Completion Date
May 31, 2013
Sunitinib
Taken orally on days 1-7 prior to surgery and then starting again on Day 22 for 4 weeks followed by a 2 week rest period
Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston
Collaborators (1)
Brigham and Women's Hospital
OTHER
Dana-Farber Cancer Institute
OTHER
Pfizer
INDUSTRY
Massachusetts General Hospital
OTHER